March 5, 2020 / 12:34 PM / in a month

BRIEF-Syros Reports Q4 Loss Per Share $0.46

March 5 (Reuters) - Syros Pharmaceuticals Inc:

* SYROS REPORTS FOURTH QUARTER 2019 FINANCIAL RESULTS AND HIGHLIGHTS KEY ACCOMPLISHMENTS AND UPCOMING MILESTONES

* Q4 LOSS PER SHARE $0.46

* Q4 EARNINGS PER SHARE ESTIMATE $-0.47 — REFINITIV IBES DATA

* Q4 REVENUE ESTIMATE $691,000 — REFINITIV IBES DATA

* SYROS PHARMACEUTICALS - WELL-FUNDED WITH CASH RUNWAY INTO 2022 BEYOND MULTIPLE EXPECTED CLINICAL DATA READOUTS FOR SY-1425 AND SY-5609 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below